Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Ringvall, Maria ^a   Thulin, Åsa ^a   Zhang, Lei ^a,d   Cedervall, Jessica ^a   Tsuchida Straeten, Nobuko ^b   Jahnen Dechent, Willi ^b   Siegbahn, Agneta ^c   Olsson, Anna Karin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB ALPHA; HISTIDINE RICH GLYCOPROTEIN; PLASMA PROTEIN; UNCLASSIFIED DRUG; GLYCOPROTEIN; HISTIDINE RICH PROTEINS; HISTIDINE-RICH PROTEINS; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING TIME; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; INSULINOMA; MOUSE; NONHUMAN; PANCREAS ISLET; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; ANIMAL; BLOOD CLOTTING; GENETICS; MOUSE MUTANT; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY);

MUS;

ANIMALS; BLOOD COAGULATION; GLYCOPROTEINS; MICE; MICE, KNOCKOUT; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET ACTIVATION; PROTEINS; TUMOR BURDEN;

EID: 79251567681     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014526     Document Type: Article

References (28)

1. Juarez JC, Guan X, Shipulina NV, Plunkett ML, Parry GC, et al. (2002) Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain. Cancer Res 62: 5344-5350.
2. Olsson AK, Larsson H, Dixelius J, Johansson I, Lee C, et al. (2004) A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Cancer Res 64: 599-605.
3. Thulin A, Ringvall M, Dimberg A, Karehed K, Vaisanen T, et al. (2009) Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein. Mol Cancer Res 7: 1792-1802.
4. Jones AL, Hulett MD, Parish CR (2005) Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol 83: 106-118.
5. Hulett MD, Parish CR (2000) Murine histidine-rich glycoprotein: cloning, characterization and cellular origin. Immunol Cell Biol 78: 280-287.
6. Leung LL, Harpel PC, Nachman RL, Rabellino EM (1983) Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 62: 1016-1021.
7. Tsuchida-Straeten N, Ensslen S, Schafer C, Woltje M, Denecke B, et al. (2005) Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost 3: 865-872.
8. Browder T, Folkman J, Pirie-Shepherd S (2000) The hemostatic system as a regulator of angiogenesis. J Biol Chem 275: 1521-1524.
9. Jurk K, Kehrel BE (2005) Platelets: physiology and biochemistry. Semin Thromb Hemost 31: 381-392.
10. Jurasz P, Alonso-Escolano D, Radomski MW (2004) Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143: 819-826.
11. Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, et al. (2006) Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A 103: 855-860.
12. Gasic GJ, Gasic TB, Stewart CC (1968) Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 61: 46-52.
13. Staton CA, Lewis CE (2005) Angiogenesis inhibitors found within the haemostasis pathway. J Cell Mol Med 9: 286-302.
14. Pipili-Synetos E, Papadimitriou E, Maragoudakis ME (1998) Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol 125: 1252-1257.
15. Verheul HM, Jorna AS, Hoekman K, Broxterman HJ, Gebbink MF, et al. (2000) Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 96: 4216-4221.
16. Brill A, Elinav H, Varon D (2004) Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 63: 226-235.
17. Chiodoni C, Iezzi M, Guiducci C, Sangaletti S, Alessandrini I, et al. (2006) Triggering CD40 on endothelial cells contributes to tumor growth. J Exp Med 203: 2441-2450.
18. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, et al. (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64: 8613-8619.
19. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812.
20. Workman P, Balmain A, Hickman JA, McNally NJ, Rohas AM, et al. (1988) UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim 22: 195-201.
21. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, et al. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Apmis 96: 379-394.
22. Nierodzik ML, Karpatkin S (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10: 355-362.
23. Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A (2007) The history of the angiogenic switch concept. Leukemia 21: 44-52.
24. Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD (2010) Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood.
25. Leung LL (1986) Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 77: 1305-1311.
26. Italiano JE, Jr., Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, et al. (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111: 1227-1233.
27. Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22: 231-237.
28. Ferrara N (2010) Role of myeloid cells in vascular endothelial growth factorindependent tumor angiogenesis. Curr Opin Hematol 17: 219-224.